Together with the observation that MYCN levels were undetectable or low in target cells before first occurrence of OB tumors and increased with tumor growth, the incomplete penetrance might be explained by variability of MYCN accumulation, which does not always reach the threshold required for tumor development. The gene discussed is MYCN; the disease is neoplasm.